Prospective Validation of the STOPSHOCK Score - Artificial Intelligence Based Predictive Scoring System to Identify the Risk of Developing Cardiogenic Shock (CS) in Patients Suffering From Acute Coronary Syndrome (ACS)
NCT ID: NCT07090382
Last Updated: 2025-07-29
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
ENROLLING_BY_INVITATION
1046 participants
OBSERVATIONAL
2025-06-01
2026-04-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The aim of this study is to prospectively validate the STOPSHOCK score on a large cohort of ACS patients in a real- world clinical environment.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
The Effects of IABP Prior to Revascularization on Mortality of ACS Patients Complicated With Cardiogenic Shock
NCT03635840
Cardiogenic Shock Working Group Registry
NCT04682483
Efficacy and Safety of Synchronized Cardiac Support in Cardiogenic Shock Patients
NCT05106491
LATIN SHOCK: Latin American Registry of Cardiogenic Shock in the Context of Acute Coronary Syndrome
NCT05246683
Aortic Balloon Counterpulastion in Myocardial Infarction Related Shock
NCT00469248
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The primary objective of this study is to prospectively validate the STOPSHOCK score on a large cohort of ACS patients. The methods and results of this project follow the Transparent Reporting of a multivariable prediction model for Individual Prognosis Or Diagnosis (TRIPOD) statement.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
ACS Patients Admitted to CCU
This cohort includes adult patients (age \>18 years) admitted to the coronary care unit (CCU) or intensive care unit (ICU) with a diagnosis of acute coronary syndrome (ACS), including STEMI, NSTEMI, and unstable angina. Patients are enrolled at the time of admission before the development of cardiogenic shock. The STOPSHOCK score is calculated using clinical variables available at first contact. Patients are followed during hospitalization to determine whether cardiogenic shock develops. No intervention is applied.
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Admitted for acute coronary syndrome in CCU
Exclusion Criteria
* Patients in CSWG-SCAI C, D or E CS the before the admission to CCU.
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Premedix Academy
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Allan Böhm, MD, PhD, MSc, MBA, FESC, FJCS
Role: PRINCIPAL_INVESTIGATOR
Premedix Academy
Branislav Bezák, MD, PhD
Role: STUDY_DIRECTOR
Premedix Academy
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Premedix Academy
Bratislava, , Slovakia
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Moons KG, Altman DG, Reitsma JB, Ioannidis JP, Macaskill P, Steyerberg EW, Vickers AJ, Ransohoff DF, Collins GS. Transparent Reporting of a multivariable prediction model for Individual Prognosis or Diagnosis (TRIPOD): explanation and elaboration. Ann Intern Med. 2015 Jan 6;162(1):W1-73. doi: 10.7326/M14-0698.
Böhm A, Jajcay N, Spartalis M, et al. Abstract 14290: Prospective Clinical Validation of the STOPSHOCK Smartphone Application - Artificial Intelligence Model for Prediction of Cardiogenic Shock in Patients With Acute Coronary Syndrome. Circulation 2023; 148.
Tran V, Pham H, Yang B-S, Nguyen T. Machine performance degradation assessment and remaining useful life prediction using proportional hazard model and support vector machine. Mechanical Systems and Signal Processing 2012; 32: 320-30.
Grohmann J, Nicholson P, Iglesias J, Kounev S, Lugones D. Monitorless: Predicting Performance Degradation in Cloud Applications with Machine Learning; 2019.
Bohm A, Segev A, Jajcay N, Krychtiuk KA, Tavazzi G, Spartalis M, Kollarova M, Berta I, Jankova J, Guerra F, Pogran E, Remak A, Jarakovic M, Sebenova Jerigova V, Petrikova K, Matetzky S, Skurk C, Huber K, Bezak B. Machine learning-based scoring system to predict cardiogenic shock in acute coronary syndrome. Eur Heart J Digit Health. 2025 Jan 6;6(2):240-251. doi: 10.1093/ehjdh/ztaf002. eCollection 2025 Mar.
Bagai J, Brilakis ES. Update in the Management of Acute Coronary Syndrome Patients with Cardiogenic Shock. Curr Cardiol Rep. 2019 Mar 4;21(4):17. doi: 10.1007/s11886-019-1102-3.
De Luca L, Olivari Z, Farina A, Gonzini L, Lucci D, Di Chiara A, Casella G, Chiarella F, Boccanelli A, Di Pasquale G, De Servi S, Bovenzi FM, Gulizia MM, Savonitto S. Temporal trends in the epidemiology, management, and outcome of patients with cardiogenic shock complicating acute coronary syndromes. Eur J Heart Fail. 2015 Nov;17(11):1124-32. doi: 10.1002/ejhf.339. Epub 2015 Sep 4.
Thiele H, Zeymer U. Cardiogenic shock in patients with acute coronary syndromes. In: Tubaro M, Vranckx P, Price S, Vrints C, eds. The ESC Textbook of Intensive and Acute Cardiovascular Care: Oxford University Press; 2015: 0.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
012025
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.